Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 145 | 539-21-9 |
| Dose | Unit | Route |
|---|---|---|
| 40 | mg | O |
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | -0.333 | Moderate | 0.68 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 1.014 | Moderate | 0.68 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 1.799 | 10^-6 cm/s | Moderate | 0.68 |
| dh-clint | Dog hepatocyte intrinsic clearance | 1.589 | uL/min/10^6 cells | Moderate | 0.68 |
| dppb | Dog plasma protein binding (% unbound) | 91.060 | % | Moderate | 0.68 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 89.590 | % | Moderate | 0.68 |
| herg | hERG pIC50 | 4.122 | pIC50 | Moderate | 0.68 |
| hh-clint | Human hepatocyte intrinsic clearance | 3.342 | uL/min/10^6 cells | Moderate | 0.68 |
| hlm-clint | Human liver microsomal intrinsic clearance | 4.539 | uL/min/mg protein | Moderate | 0.68 |
| hppb | Human plasma protein binding (% unbound) | 74.080 | % | Moderate | 0.68 |
| kinase-safety-class | ACVR2A,ACVR2B,ACVRL1,AKT1,AKT2,AKT3,ALK,AURKA,AURKB,AURKC,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK1,CDK4,CDK5,CDK9,CHEK1,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHA2,EPHB4,ERBB2,FGFR1,FLT1,FLT3,FLT4,GRK2,GRK3,GSK3A,GSK3B,IGF1R,IKBKB,IRAK1,ITK,JAK1,JAK2,JAK3,KDR,KIT,MAP2K1,MAP2K6,MAP3K1,MAP3K10,MAP3K11,MAP3K14,MAP3K2,MAP3K21,MAP3K3,MAP3K7,MAP4K1,MAP4K3,MAP4K5,MAPK1,MAPK10,MAPK12,MAPK14,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK5,MARK4,MELK,MET,MTOR,NTRK2,PAK4,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIM1,PIM2,PIM3,PLK1,PLK2,PLK3,PLK4,PRKCD,PRKDC,SGK1,SIK2,SIK3,SRC,STK10,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ULK2,ZAP70 | 102 | |||
| kinase-selectivity-class | ACVR2A,ACVR2B,AURKB,AURKC,AXL,BRAF,CAMK2D,CDK16,CDK3,CDK4,CDK9,CLK2,CLK4,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FGFR1,GRK2,GSK3A,GSK3B,HIPK2,IKBKB,IRAK1,JAK2,MAP2K3,MAP2K6,MAP3K14,MAP3K2,MAP3K21,MAP3K7,MAPK12,MAPK7,MARK4,PIK3CB,PIM3,PRKAA1,PRKDC,SIK2,STK10,STK33,SYK,TEK,TGFBR1,TTK,UHMK1,ULK1,ULK2 | 49 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 1.026 | Moderate | 0.68 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 2.600 | Moderate | 0.68 | |
| mppb | Mouse plasma protein binding (% unbound) | 89.460 | Moderate | 0.68 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 1.028 | Moderate | 0.68 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 87.220 | % | Moderate | 0.68 |
| rh-clint | Rat hepatocyte intrinsic clearance | 1.866 | uL/min/10^6 cells | Moderate | 0.68 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 95.280 | % | Moderate | 0.68 |
| rppb | Rat plasma protein binding (% unbound) | 81.360 | % | Moderate | 0.68 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 881.049 | uM | Moderate | 0.68 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | R02AA01 | RESPIRATORY SYSTEM THROAT PREPARATIONS THROAT PREPARATIONS Antiseptics |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.84 | acidic |
| pKa2 | 11.71 | acidic |
| pKa3 | 9.28 | Basic |
| pKa4 | 6.43 | Basic |
| pKa5 | 0.0 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Polyphenol oxidase 2 | Enzyme | IC50 | 4.82 | CHEMBL | |||||
| Zinc finger protein mex-5 | Cytosolic other | EC50 | 5.01 | CHEMBL | |||||
| Cytoplasmic zinc-finger protein | Cytosolic other | EC50 | 4.12 | CHEMBL |
| ID | Source |
|---|---|
| D07376 | KEGG_DRUG |
| C0043983 | UMLSCUI |
| CHEBI:134962 | CHEBI |
| CHEMBL2103762 | ChEMBL_ID |
| DB13697 | DRUGBANK_ID |
| 1549158 | PUBCHEM_CID |
| 822 | INN_ID |
| BYK4592A3Q | UNII |
None